Alexis Demonbreun to Muscular Dystrophy, Duchenne
This is a "connection" page, showing publications Alexis Demonbreun has written about Muscular Dystrophy, Duchenne.
Connection Strength
3.048
-
Distribution of MRI-derived T2 values as a biomarker for in vivo rapid screening of phenotype severity in mdx mice. PLoS One. 2024; 19(9):e0310551.
Score: 0.921
-
Anti-latent TGFß binding protein 4 antibody improves muscle function and reduces muscle fibrosis in muscular dystrophy. Sci Transl Med. 2021 Sep 08; 13(610):eabf0376.
Score: 0.746
-
Myoferlin regulation by NFAT in muscle injury, regeneration and repair. J Cell Sci. 2010 Jul 15; 123(Pt 14):2413-22.
Score: 0.343
-
Serum protein and imaging biomarkers after intermittent steroid treatment in muscular dystrophy. Sci Rep. 2024 11 20; 14(1):28745.
Score: 0.233
-
Physiological stress improves stem cell modeling of dystrophic cardiomyopathy. Dis Model Mech. 2024 Jun 01; 17(6).
Score: 0.220
-
Effects of Glucocorticoids in Murine Models of Duchenne and Limb-Girdle Muscular Dystrophy. Methods Mol Biol. 2023; 2587:467-478.
Score: 0.204
-
Pulsed glucocorticoids enhance dystrophic muscle performance through epigenetic-metabolic reprogramming. JCI Insight. 2019 12 19; 4(24).
Score: 0.166
-
"Of Mice and Measures": A Project to Improve How We Advance Duchenne Muscular Dystrophy Therapies to the Clinic. J Neuromuscul Dis. 2018; 5(4):407-417.
Score: 0.145
-
Intermittent Glucocorticoid Dosing Improves Muscle Repair and Function in Mice with Limb-Girdle Muscular Dystrophy. Am J Pathol. 2017 Nov; 187(11):2520-2535.
Score: 0.035
-
Intermittent glucocorticoid steroid dosing enhances muscle repair without eliciting muscle atrophy. J Clin Invest. 2017 Jun 01; 127(6):2418-2432.
Score: 0.035